• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

No increased rate of SARS-CoV-2 infection for patients with inflammatory rheumatic diseases compared with the general population in the city of Hamburg (Germany).

作者信息

Aries Peer, Iking-Konert Christof

机构信息

Rheumatologie und klinische Immunolgie, Rheumatologie im Struenseehaus, Hamburg, Germany.

Nephrology and Rheumatology, Department of Medicine III, University of Hamburg Faculty of Medicine, Hamburg, Germany

出版信息

Ann Rheum Dis. 2022 Dec;81(12):e245. doi: 10.1136/annrheumdis-2020-218400. Epub 2020 Aug 7.

DOI:10.1136/annrheumdis-2020-218400
PMID:32769151
Abstract
摘要

相似文献

1
No increased rate of SARS-CoV-2 infection for patients with inflammatory rheumatic diseases compared with the general population in the city of Hamburg (Germany).与德国汉堡市的普通人群相比，炎症性风湿病患者感染新冠病毒的几率并未增加。
Ann Rheum Dis. 2022 Dec;81(12):e245. doi: 10.1136/annrheumdis-2020-218400. Epub 2020 Aug 7.
2
COVID-19, rheumatic diseases and immune dysregulation-a perspective.COVID-19 与风湿性疾病和免疫失调：一个观察视角。
Clin Rheumatol. 2021 Feb;40(2):433-442. doi: 10.1007/s10067-020-05529-y. Epub 2021 Jan 7.
3
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study.新冠病毒感染在伴有和不伴有炎症性风湿病个体中的结局：一项丹麦全国队列研究。
Ann Rheum Dis. 2023 Oct;82(10):1359-1367. doi: 10.1136/ard-2023-223974. Epub 2023 Jul 6.
4
SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey.SARS-CoV-2 血清阳性率在自身免疫性风湿病患者与家族对照者中的比较：一项多城市横断面研究。
Rheumatol Int. 2024 Jan;44(1):81-87. doi: 10.1007/s00296-023-05489-x. Epub 2023 Oct 31.
5
[Rheumatology in Germany in the SARS-CoV-2 pandemic].[德国SARS-CoV-2大流行期间的风湿病学]
Z Rheumatol. 2024 Sep;83(7):517-519. doi: 10.1007/s00393-024-01573-0. Epub 2024 Sep 30.
6
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.COVID-19 与风湿性自身免疫性系统性疾病：一项大型意大利患者系列报告。
Clin Rheumatol. 2020 Nov;39(11):3195-3204. doi: 10.1007/s10067-020-05334-7. Epub 2020 Aug 27.
7
Evolution of COVID-19 in patients with autoimmune rheumatic diseases.COVID-19 在自身免疫性风湿病患者中的演变。
Aging (Albany NY). 2020 Dec 3;12(23):23427-23435. doi: 10.18632/aging.202193.
8
Perceived Risk of SARS-CoV-2 at the Start of the COVID-19 Pandemic and Subsequent Vaccination Attitudes in Patients With Rheumatic Diseases: A Longitudinal Analysis.COVID-19 大流行开始时对 SARS-CoV-2 的感知风险以及随后风湿性疾病患者的疫苗接种态度：一项纵向分析。
J Clin Rheumatol. 2022 Jun 1;28(4):190-195. doi: 10.1097/RHU.0000000000001826. Epub 2022 Jan 24.
9
Prevalence and Risk Factors of Postacute Sequelae of COVID-19 in Adults With Systemic Autoimmune Rheumatic Diseases.COVID-19 后急性后遗症在患有系统性自身免疫性风湿病的成年人中的流行情况和危险因素。
J Rheumatol. 2024 Sep 1;51(9):928-933. doi: 10.3899/jrheum.2023-1212.
10
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.德国炎症性风湿病（IRD）患者感染 SARS-CoV-2 的国家登记处（ReCoVery）：了解 IRD 患者 SARS-CoV-2 感染临床病程的快速可靠知识的宝贵手段。
RMD Open. 2020 Sep;6(2). doi: 10.1136/rmdopen-2020-001332.

引用本文的文献

1
Perception of COVID-19 vaccines in rheumatology patients.风湿病患者对新冠疫苗的认知
Medicine (Baltimore). 2025 Aug 1;104(31):e43618. doi: 10.1097/MD.0000000000043618.
2
MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS Register.新冠疫情之前、期间及之后的多发性硬化症治疗趋势：来自德国多发性硬化症登记处的见解
J Neurol. 2025 Mar 26;272(4):294. doi: 10.1007/s00415-025-13010-6.
3
Prevalence of coronavirus disease 2019 in a multiethnic cohort of patients with autoimmune rheumatic diseases in Qatar.
卡塔尔自身免疫性风湿病多民族患者队列中2019冠状病毒病的患病率
Qatar Med J. 2022 Aug 5;2022(3):37. doi: 10.5339/qmj.2022.37. eCollection 2022.
4
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study.系统性硬化症患者 COVID-19 的严重程度和死亡率：巴西多中心研究。
Semin Arthritis Rheum. 2022 Aug;55:151987. doi: 10.1016/j.semarthrit.2022.151987. Epub 2022 Feb 25.
5
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre.COVID-19 大流行对多发性硬化症转诊中心临床就诊频率、MRI 研究开展情况和治疗选择的影响。
J Neurol. 2022 Apr;269(4):1764-1772. doi: 10.1007/s00415-021-10958-z. Epub 2022 Jan 10.
6
Association between previous rheumatoid arthritis and COVID-19 and its severity: a nationwide cohort study in South Korea.既往类风湿关节炎与新型冠状病毒肺炎及其严重程度之间的关联：韩国一项全国性队列研究
BMJ Open. 2021 Oct 7;11(10):e054753. doi: 10.1136/bmjopen-2021-054753.
7
Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis.与普通人群相比，风湿性疾病患者感染新型冠状病毒肺炎的风险及临床结局：一项系统评价和荟萃分析。
Rheumatol Int. 2021 May;41(5):851-861. doi: 10.1007/s00296-021-04803-9. Epub 2021 Mar 9.
8
Inflammatory arthritis in patients with COVID-19.COVID-19 患者的炎症性关节炎。
Transl Res. 2021 Jun;232:49-59. doi: 10.1016/j.trsl.2021.02.010. Epub 2021 Feb 21.
9
Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data.COVID-19 患者风湿性疾病的临床结局：全球数据的系统评价和荟萃分析。
Autoimmun Rev. 2021 Apr;20(4):102778. doi: 10.1016/j.autrev.2021.102778. Epub 2021 Feb 18.
10
A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.单中心自身免疫和免疫介导性疾病伴有症状 COVID-19 患者的多学科登记研究。
J Autoimmun. 2021 Feb;117:102580. doi: 10.1016/j.jaut.2020.102580. Epub 2020 Nov 30.